DOCTORAL
CANDIDATES
Background
My academic career began with a Bachelor’s degree in Biotechnology at Pablo de Olavide University in Seville, Spain, followed by a Master’s degree in Molecular and Cellular Biology at the University of Heidelberg in Germany. During this period, I also worked part-time as a Student Research Assistant at the German Cancer Research Center (DKFZ).
For my Master’s thesis, I conducted research on the carcinoma tumour microenvironment using gene knock-out approaches, at the University of Queensland in Brisbane, Australia. Afterwards, I worked as a Research Assistant in the Regenerative Medicine group at the Queensland University of Technology, where I focused on developing and analysing 3D culture models.
Research
I started my PhD within the NUCLEAR doctoral network at the Karolinska Insitutet in Stockholm, Sweden, in September 2025. In the Andreas Lennartsson lab, my project explores how metabolic enzymes influence gene regulation in acute myeloid leukemia (AML) through epigenetic mechanisms. Focusing on their non-canonical “moonlighting” roles in the nucleus, we seek to understand how these enzymes are recruited to chromatin, potentially through long non-coding RNAs and transcription factors. Further, we aim to characterise novel metabolism-linked histone modifications, which may drive or supress leukemogenesis. Ultimately, the work aims to uncover how these processes drive leukemia progression and lineage switching, identifying potential therapeutic targets.